Article info
PDFNeuro-inflammation
Research paper
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
- Correspondence to Jackie Palace, Nuffield Department of Clinical Neurosciences, West Wing, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK; jacqueline.palace{at}ndcn.ox.ac.uk
Citation
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
Publication history
- Received December 13, 2012
- Revised February 6, 2013
- Accepted February 7, 2013
- First published March 6, 2013.
Online issue publication
February 13, 2017
Article Versions
- Previous version (13 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions